Triangle Securities Wealth Management Sells 50 Shares of Equifax Inc. (NYSE:EFX)

Triangle Securities Wealth Management decreased its holdings in shares of Equifax Inc. (NYSE:EFX) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,203 shares of the credit services provider’s stock after selling 50 shares during the period. Triangle Securities Wealth Management’s holdings in Equifax were worth $816,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Susquehanna Fundamental Investments LLC bought a new position in shares of Equifax during the second quarter valued at approximately $15,646,000. Barclays PLC increased its position in Equifax by 2.8% during the 3rd quarter. Barclays PLC now owns 184,890 shares of the credit services provider’s stock valued at $54,329,000 after purchasing an additional 5,097 shares during the period. Dimensional Fund Advisors LP raised its holdings in Equifax by 16.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 584,820 shares of the credit services provider’s stock worth $141,789,000 after purchasing an additional 81,966 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Equifax by 3.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 6,397 shares of the credit services provider’s stock worth $1,880,000 after purchasing an additional 231 shares during the period. Finally, Intech Investment Management LLC boosted its stake in shares of Equifax by 84.1% during the 3rd quarter. Intech Investment Management LLC now owns 6,861 shares of the credit services provider’s stock valued at $2,016,000 after purchasing an additional 3,135 shares in the last quarter. Hedge funds and other institutional investors own 96.20% of the company’s stock.

Equifax Stock Down 0.5 %

EFX stock opened at $262.87 on Friday. The stock has a market capitalization of $32.58 billion, a P/E ratio of 58.42, a P/E/G ratio of 2.43 and a beta of 1.57. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.88 and a quick ratio of 0.88. Equifax Inc. has a 1-year low of $213.02 and a 1-year high of $309.63. The business has a fifty day moving average price of $258.08 and a 200-day moving average price of $273.27.

Equifax (NYSE:EFX) last issued its earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. Equifax had a return on equity of 18.56% and a net margin of 10.07%. Equifax’s revenue was up 9.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.76 EPS. Equities analysts forecast that Equifax Inc. will post 7.28 earnings per share for the current fiscal year.

Equifax Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Stockholders of record on Friday, November 22nd were issued a dividend of $0.39 per share. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $1.56 annualized dividend and a dividend yield of 0.59%. Equifax’s payout ratio is 34.67%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Wells Fargo & Company lowered their target price on Equifax from $325.00 to $321.00 and set an “overweight” rating for the company in a research note on Friday, January 10th. Needham & Company LLC reissued a “buy” rating and set a $350.00 price objective on shares of Equifax in a research report on Monday, October 28th. Wolfe Research downgraded shares of Equifax from an “outperform” rating to a “peer perform” rating in a research report on Thursday, December 12th. Stifel Nicolaus lowered their price target on shares of Equifax from $305.00 to $284.00 and set a “buy” rating for the company in a research report on Wednesday, November 20th. Finally, Robert W. Baird boosted their price objective on shares of Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Two analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $311.12.

Insider Activity at Equifax

In related news, CEO Mark W. Begor sold 58,304 shares of the company’s stock in a transaction on Friday, October 25th. The stock was sold at an average price of $270.49, for a total transaction of $15,770,648.96. Following the completion of the sale, the chief executive officer now owns 109,183 shares in the company, valued at approximately $29,532,909.67. This represents a 34.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Lisa M. Nelson sold 551 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $260.39, for a total value of $143,474.89. Following the completion of the transaction, the executive vice president now directly owns 11,697 shares in the company, valued at approximately $3,045,781.83. This represents a 4.50 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 59,855 shares of company stock worth $16,187,044 over the last quarter. Company insiders own 1.66% of the company’s stock.

Equifax Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.